Crinetics Pharmaceuticals, Inc. (CRNX)
NASDAQ: CRNX · Real-Time Price · USD
34.20
+0.10 (0.29%)
At close: Sep 17, 2025, 4:00 PM EDT
34.62
+0.42 (1.23%)
After-hours: Sep 17, 2025, 7:24 PM EDT
Crinetics Pharmaceuticals Market Cap
Crinetics Pharmaceuticals has a market cap or net worth of $3.22 billion as of September 17, 2025. Its market cap has decreased by -23.64% in one year.
Market Cap
3.22B
Enterprise Value
2.07B
1-Year Change
-23.64%
Ranking
Category
Stock Price
$34.20
Market Cap Chart
Since July 18, 2018, Crinetics Pharmaceuticals's market cap has increased from $563.93M to $3.22B, an increase of 471.14%. That is a compound annual growth rate of 27.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2025 | 3.21B | -32.27% |
| Dec 31, 2024 | 4.74B | 99.51% |
| Dec 29, 2023 | 2.38B | 141.36% |
| Dec 30, 2022 | 984.73M | -26.50% |
| Dec 31, 2021 | 1.34B | 188.40% |
| Dec 31, 2020 | 464.53M | -23.56% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jul 18, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 688.68B |
| Johnson & Johnson | 429.67B |
| AbbVie | 387.41B |
| UnitedHealth Group | 309.07B |
| Novo Nordisk | 253.09B |
| AstraZeneca | 240.11B |
| Novartis AG | 237.94B |
| Abbott Laboratories | 232.94B |